Screener
Fulgent Genetics, Inc. FLGT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Customer deposits | 2,470 | 83 |
| Accrued liabilities and other liabilities | (2,123) | (7,485) |
| Operating lease liabilities | (381) | (354) |
| Net cash provided by (used in) operating activities | 7,097 | (4,431) |
| Cash flow from investing activities: | ||
| Maturities of marketable securities | 81,711 | 32,445 |
| Proceeds from sale of fixed assets | 8 | 2 |
| Purchase of marketable securities | (10,011) | — |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s operating cash flow?
- Fulgent Genetics, Inc. (FLGT) reported operating cash flow of $7.1M in Q1 2026.
- How has Fulgent Genetics, Inc.'s operating cash flow changed year-over-year?
- Fulgent Genetics, Inc.'s operating cash flow increased by 260.2% year-over-year, from -$4.43M to $7.1M.
- What is the long-term trend for Fulgent Genetics, Inc.'s operating cash flow?
- Over 3 years (2021 to 2024), Fulgent Genetics, Inc.'s operating cash flow has grown at a -66.1% compound annual growth rate (CAGR), from $538.58M to $21.06M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Fulgent Genetics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude